Aptinyx Appears To Be Moving On From Pain With Fibromyalgia Miss

nerve cells, concept for neurodegenerative and neurological disease
Another setback in chronic pain leaves Aptinyx focusing on PTSD, dementia

More from Clinical Trials

More from R&D